Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro

BACKGROUND: For Glioblastoma (GBM) patients, a number of anti-neoplastic strategies using specifically targeting drugs have been tested; however, the effects on survival have been limited. One explanation could be treatment resistance due to redundant signaling pathways, which substantiates the need...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Cell Int
Main Authors: Staberg, Mikkel, Michaelsen, Signe Regner, Olsen, Louise Stobbe, Nedergaard, Mette Kjølhede, Villingshøj, Mette, Stockhausen, Marie-Thérése, Hamerlik, Petra, Poulsen, Hans Skovgaard
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2016
נושאים:
Primary Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845362/
https://ncbi.nlm.nih.gov/pubmed/27118928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0309-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים